# Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial

> **NCT04405258** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Institute for Clinical Effectiveness, Japan** · enrollment: 276 (actual)

## Conditions studied

- Persistent Atrial Fibrillation
- Catheter Ablation
- Pulmonary Vein Isolation
- Posterior Wall Isolation

## Interventions

- **PROCEDURE:** Pulmonary vein isolation
- **PROCEDURE:** Left posterior wall isolation

## Key facts

- **NCT ID:** NCT04405258
- **Lead sponsor:** Institute for Clinical Effectiveness, Japan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-06-08
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 276 (ACTUAL)
- **Last updated:** 2024-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04405258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04405258, "Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04405258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*